Values First Advisors, Inc. Edwards Lifesciences Corp Transaction History

Values First Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $6,237 - $7,098	84 New	84 $6,000
Q2 2022 Jul 20, 2022	SELL	$86.5 - $128.27 $1.78 Million - $2.65 Million	-20,632 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$101.96 - $128.34 $26,713 - $33,625	262 Added 1.29%	20,632 $2.43 Million
Q4 2021 Mar 10, 2022	BUY	$106.37 - $130.68 $2.17 Million - $2.66 Million	20,370 New	20,370 $2.64 Million
Q3 2021 Nov 15, 2022	BUY	$102.91 - $122.75 $2.44 Million - $2.91 Million	23,672 New	23,672 $2.68 Million
Q2 2021 Nov 15, 2022	BUY	$83.84 - $104.76 $534,312 - $667,635	6,373 Added 37.52%	23,360 $2.42 Million
Q1 2021 Nov 15, 2022	BUY	$78.68 - $90.67 $1.34 Million - $1.54 Million	16,987 New	16,987 $1.42 Million
Q4 2020 Nov 15, 2022	BUY	$71.69 - $91.23 $71 - $91	1 Added 0.01%	16,669 $1.52 Million
Q3 2020 Nov 15, 2022	BUY	$67.19 - $87.44 $8,801 - $11,454	131 Added 0.79%	16,668 $1.33 Million
Q2 2020 Nov 15, 2022	BUY	$57.54 - $76.95 $518,205 - $693,011	9,006 Added 119.59%	16,537 $1.14 Million
Q1 2020 Jan 09, 2023	BUY	$52.41 - $81.0 $416,240 - $643,302	7,942 New	7,942 $1.5 Billion
Q4 2019 Nov 15, 2022	BUY	$71.7 - $82.09 $539,972 - $618,219	7,531 New	7,531 $1.76 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.